Clinical Trials Directory

Trials / Terminated

TerminatedNCT01642459

The Outcomes of Arteriovenous Fistula Cannulated From Different Direction.

The Outcomes of Arteriovenous Fistula (AVF) Cannulated From Different Direction in Maintenance Hemodialysis Patients.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Dongliang Zhang, MD · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesis that aneurysms and stenoses will be decreased if the direction of inserted arterial needle were same as the direction of blood flow, when compared to the opposite direction puncture.

Detailed description

Native arteriovenous fistula (AVF) is the preferred access for hemodialysis, and cannulation technique is very important factors affect the outcomes of AVF. Rope-ladder cannulation is one kind of the standard puncture techniques which is used commonly in maintenance hemodialysis (MHD) patients. There are many complications for rope-ladder cannulation, such as venous aneurysm and vascular stenosis, which may induce AVF dysfunction. For the venous outflow way, there always be aneurysm followed by stenoses at the sites of needle connected with the arterial line in rope-ladder cannulation patients. The investigators hypothesis that the directions of inserted arterial needles should affect the AVF outcomes. The present prospective study will compare the outcomes of AVF between the puncture direction at arterial needle sites same as blood flow and opposite to blood flow.

Conditions

Interventions

TypeNameDescription
OTHERSame direction cannulationThe puncture direction of the arterial needle is same as the blood flow in every hemodialysis session.
OTHEROpposite direction cannulationThe puncture direction of the arterial needle is opposite to the blood flow in every hemodialysis session.

Timeline

Start date
2012-09-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2012-07-17
Last updated
2015-05-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01642459. Inclusion in this directory is not an endorsement.